Neurology

  • 27 April 2017

    Brexit impact on drug device combinations

    As the UK commences negotiations to leave the member states of the EU (colloquially known as “Brexit”), the European Commission has been swift to remove items from negotiating table.

Close
Close
Close

Go Top